| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 60.104 | 4.966 | 141.372 | 104.487 | 117.982 | 150.898 | 315.867 | 488.579 | 370.972 | 497.815 |
| Total Income - EUR | 60.339 | 24.229 | 141.372 | 104.487 | 117.992 | 150.910 | 581.885 | 489.121 | 371.089 | 498.289 |
| Total Expenses - EUR | 13.195 | 14.050 | 54.945 | 47.925 | 49.924 | 37.625 | 142.357 | 87.126 | 101.436 | 100.339 |
| Gross Profit/Loss - EUR | 47.144 | 10.179 | 86.427 | 56.563 | 68.068 | 113.285 | 439.528 | 401.995 | 269.653 | 397.950 |
| Net Profit/Loss - EUR | 45.341 | 9.694 | 85.014 | 55.518 | 66.888 | 111.892 | 434.669 | 397.704 | 266.017 | 383.301 |
| Employees | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Omniavera Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 95.244 | 91.801 | 87.081 | 82.842 | 86.509 | 86.316 | 11.296 | 106.251 | 76.417 | 49.093 |
| Current Assets | 1.130 | 1.802 | 5.545 | 2.109 | 1.780 | 29.394 | 441.480 | 390.332 | 229.791 | 354.661 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 949 | 1.520 | 513 | 1.340 | 1.739 | 1.069 | 387.104 | 384.062 | 222.084 | 347.497 |
| Cash | 181 | 281 | 5.031 | 769 | 41 | 28.325 | 54.376 | 6.270 | 7.707 | 7.164 |
| Shareholders Funds | 70.750 | 79.723 | 85.124 | 77.666 | 67.009 | 111.997 | 434.771 | 397.807 | 266.119 | 383.402 |
| Social Capital | 94 | 94 | 92 | 90 | 89 | 87 | 85 | 85 | 85 | 84 |
| Debts | 25.624 | 13.880 | 7.502 | 7.475 | 21.772 | 5.526 | 18.005 | 99.180 | 41.509 | 22.172 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Omniavera Med Srl